Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Recruiting 3Unknown 1Completed 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Classical hematology 1

Conditions

Marijuana Abuse 3Neoplasms 2Epilepsy 2Tourette Syndrome 1Stress Disorders, Post-Traumatic 1Sleep Initiation and Maintenance Disorders 1Severe Acute Respiratory Syndrome 1Seizures 1Parkinson Disease 1Pancreatic Cancer Non-resectable 1Pain 1Opioid-Related Disorders 1Neurodevelopmental Disorders 1Multiple Sclerosis 1Marijuana Use 1Inflammatory Bowel Diseases 1Hepatitis C 1Glaucoma 1Fibromyalgia 1Depression 1Crohn Disease 1Coronavirus Infections 1Colitis, Ulcerative 1Chronic Traumatic Encephalopathy 1Chronic Pain 1Carcinoma, Hepatocellular 1COVID-19 1Brain Injuries, Traumatic 1Bipolar Disorder 1Autistic Disorder 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Medical Marijuana × Clear all
NCT04827992 2025-11-05

Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain

Massachusetts General Hospital

Phase NA Completed
87 enrolled

Marijuana Use, Marijuana Abuse, Pain

NCT06605430 2025-07-29

CanPan-C

HealthPartners Institute

Phase 2 Recruiting
64 enrolled
Gastrointestinal

Pancreatic Cancer Non-resectable

NCT06518434 2024-07-24

CanHep

University Medical Center Groningen

Phase 2 Recruiting
20 enrolled
Gastrointestinal

Marijuana Abuse, Carcinoma, Hepatocellular

NCT05863910 2023-11-30

CAN-RWE

University of Manitoba

Recruiting
500 enrolled

Marijuana Abuse, Epilepsy, Neoplasms, Neurodevelopmental Disorders

NCT03944447 2022-06-02

OMNI-Can

OMNI Medical Services, LLC

Phase 2 Unknown
200,000 enrolled
Classical hematology

Chronic Traumatic Encephalopathy, Brain Injuries, Traumatic, COVID-19, Acquired Immunodeficiency Syndrome, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Anxiety Disorders, Autistic Disorder, Bipolar Disorder, Colitis, Ulcerative, Crohn Disease, Depression, Epilepsy, Fibromyalgia, Tourette Syndrome, Glaucoma, Hepatitis C, Sleep Initiation and Maintenance Disorders, Multiple Sclerosis, Opioid-Related Disorders, Neoplasms, Parkinson Disease, Seizures, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Coronavirus Infections, Severe Acute Respiratory Syndrome, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡